A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages-Reference-Cited by-同舟云学术

A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages

Published:2014-05 Issue:22 Volume:32 Page:2623-2630
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Theisen Michael,Roeffen Will,Singh Susheel K.,Andersen Gorm,Amoah Linda,van de Vegte-Bolmer Marga,Arens Theo,Tiendrebeogo Régis Wendpayangde,Jones Sophie,Bousema Teun,Adu Bright,Dziegiel Morten H.,Christiansen Michael,Sauerwein Robert

Funder

Ministry of Science, Innovation and Higher Education

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference47 articles.

1. Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies;Griffin;PLoS Med,2010

2. A research agenda to underpin malaria eradication;Alonso;PLoS Med,2011

3. A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli;Chowdhury;PLoS One,2009

4. Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice;Outchkourov;Proc Natl Acad Sci U S A,2008

5. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination;Bousema;Clinical Microbiology Reviews,2011

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults;Journal of Clinical Investigation;2024-04-01

2. Clinical formulation development of Plasmodium falciparum malaria vaccine candidates based on Pfs48/45, Pfs230, and PfCSP;Vaccine;2024-03

3. Pfs230 Domain 7 is targeted by a potent malaria transmission-blocking monoclonal antibody;npj Vaccines;2023-12-12

4. Design of a stabilized non-glycosylated Pfs48/45 antigen enables a potent malaria transmission-blocking nanoparticle vaccine;npj Vaccines;2023-02-18

5. Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes;Immunity;2023-02